Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FHW77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,236
Award facts
- Contract value 100% obligated
- $13,236.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,236.26 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on July 14, 2025, with completion expected by July 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The award reflects the company's established role as a critical pharmaceutical distributor for federal military and healthcare systems, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order supports the military healthcare supply chain by procuring a cardiac medication used for heart failure treatment. AmerisourceBergen's DLA IDC enables the company to supply a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The DLA Troop Support Medical contract vehicle demonstrates the agency's reliance on experienced prime vendors to provide flexible, on-demand pharmaceutical procurement capabilities to support Defense Health Agency operations and other government healthcare systems, positioning AmerisourceBergen as a key supplier within the federal medical supply ecosystem.
Quick answers
Who was awarded contract SPE2DB25FHW77?
SPE2DB25FHW77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FHW77 worth?
The government has obligated $13,236 on SPE2DB25FHW77.
Is contract SPE2DB25FHW77 an order under another contract?
Yes. SPE2DB25FHW77 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHW77 competed?
The extent of competition for SPE2DB25FHW77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award